Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Saxenda Market Report 2025

Saxenda Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Obesity Management (Body Mass Index (BMI) of =30 kg/m²), Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities)), By Dosage Form (Injection, Pre-filled pens), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals And Clinics, Homecare Settings)

Saxenda Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Saxenda Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Saxenda Market Definition

Saxenda is a prescription medication containing liraglutide, designed to aid in weight management for adults with obesity or overweight conditions. It works by mimicking a hormone in the body that regulates appetite, helping individuals reduce caloric intake and achieve sustained weight loss when combined with a reduced-calorie diet and increased physical activity.

The main indications of saxenda include obesity management (body mass index (BMI) of =30 kg/m²) and overweight management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities). Obesity is characterized by a body mass index (BMI) of 30 kg/m² or higher, indicating excessive body fat accumulation. This condition significantly increases the risk of developing chronic health issues such as type 2 diabetes, hypertension, and cardiovascular diseases. The several dosage forms include injections and pre-filled pens and are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies. The various end users include Hospitals and clinics and homecare settings.

Saxenda Market Segmentation

The saxenda market covered in this report is segmented –

1) By Indication: Obesity Management (Body Mass Index (BMI) of =30 kg/m²); Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities)

2) By Dosage Form: Injection; Pre-filled pens

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

4) By End User: Hospitals And Clinics; Homecare Settings

Saxenda Market Size and growth rate 2025 to 2029: Graph

Saxenda Market Size 2025 And Growth Rate

The saxenda market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased prevalence of obesity, growth in sedentary lifestyles, rise in awareness of obesity-related health risks, increased adoption of weight management treatments, and expansion of healthcare access.

Saxenda Market Growth Forecast

The saxenda market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing personalized medicine, expanding healthcare infrastructure, rising demand for non-surgical weight loss solutions, and increasing use of digital health tools. Major trends in the forecast period include the emergence of combination therapies for weight loss, increasing availability of prescription weight loss medications, rising adoption of digital health and fitness apps, integration of weight management solutions into primary care, and greater focus on sustainable lifestyle changes.

Book your 30 minutes free consultation with our research experts

Contact Us

Saxenda Market Driver: Rising Obesity Prevalence Drives Demand For Weight-Loss Treatments

The rising prevalence of obesity is expected to propel the growth of the saxenda market going forward. Obesity is a health condition marked by an excess of body fat, which raises the risk of various health issues like diabetes, heart disease, and certain cancers. The rising prevalence of obesity can be attributed to several factors, including unhealthy diets, sedentary lifestyles, urbanization, genetic factors, and hormonal imbalances. Saxenda helps combat obesity by regulating appetite through its active ingredient, liraglutide, which mimics the natural hormone GLP-1 to promote feelings of fullness, reduce caloric intake, and support sustainable weight loss when combined with a healthy diet and regular physical activity. For instance, in May 2024, according to a report published by the Office for Health Improvement and Disparities (OHID), a UK-based government agency, an estimated 64.0% of adults aged 18 years and over in England were overweight or living with obesity in 2022 to 2023, with 26.2% living with obesity, similar to the figures from 2021 to 2022 (63.8% and 25.9%, respectively). Therefore, the rising prevalence of obesity is driving the growth of the saxenda market.

Saxenda Market Driver: Rising Diabetes Prevalence Boosts Demand For Saxenda's Weight Management Solutions

The rising prevalence of diabetes is expected to propel the growth of the saxenda market going forward. Diabetes is a long-term condition that impacts the body's ability to regulate blood sugar (glucose) levels. The rising prevalence of diabetes is mainly due to factors such as unhealthy diets, sedentary lifestyles, obesity, aging populations, and genetic predisposition. Saxenda helps manage diabetes by leveraging its active ingredient, liraglutide, to enhance insulin sensitivity, regulate blood sugar levels, and slow gastric emptying, providing comprehensive support for glycemic control alongside its weight management benefits. For instance, in February 2023, according to a report published by Diabetes Canada, a Canada-based national charitable organization, nearly 30% of Ontario's population, or 2.4 million people, lived with diabetes or prediabetes in 2023, with a projected 25% increase in prevalence over the next decade, raising treatment costs from $1.7 billion to $2.1 billion annually by 2033. Therefore, the rising prevalence of diabetes is driving the growth of the saxenda market.

Global Saxenda Market Major Players

Major companies operating in the saxenda market are Novo Nordisk

Global Saxenda Market Trend: Innovative Generic Products Expand Affordable Alternatives For Weight Management

A key trend in the saxenda market is developing innovative products, such as generic products for weight management, to expand the availability of an affordable, approved alternative for weight management. A generic product for weight management refers to a medication that is chemically identical to a brand-name weight loss drug, providing the same therapeutic effects but marketed under its chemical name or a different brand name, typically at a lower cost. For instance, in April 2024, Biocon Limited, an India-based biopharmaceutical company, announced the approval of its generic formulation, Liraglutide (gSaxenda), by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK. This product, available as a 6 mg/ml solution in a pre-filled pen, is designed to aid in weight management when combined with a reduced-calorie diet and increased physical activity. The approval highlights the significance of cost-effective alternatives in addressing obesity, further strengthening Biocon's portfolio of vertically integrated, complex drug products.

Regional Analysis For The Global Saxenda Market

North America was the largest region in the saxenda market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the saxenda market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the saxenda market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Saxenda Market?

The saxenda market consists of sales of products such as prefilled pens of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, and 3 mg. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Saxenda Industry?

The saxenda market research report is one of a series of new reports from The Business Research Company that provides saxenda market statistics, including saxenda industry global market size, regional shares, competitors with saxenda market share, detailed saxenda market segments, market trends and opportunities, and any further data you may need to thrive in the saxenda industry. This saxenda market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Saxenda Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The saxenda market covered in this report is segmented –
1) By Indication: Obesity Management (Body Mass Index (BMI) of =30 kg/m²); Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities)
2) By Dosage Form: Injection; Pre-filled pens
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End User: Hospitals And Clinics; Homecare Settings
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Novo Nordisk
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Saxenda Market Characteristics

    3. Saxenda Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Saxenda Market Trends And Strategies

    5. Saxenda Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Saxenda Growth Analysis And Strategic Analysis Framework

    6.1. Global Saxenda PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Saxenda Market Growth Rate Analysis

    6.4. Global Saxenda Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Saxenda Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Saxenda Total Addressable Market (TAM)

    7. Global Saxenda Pricing Analysis & Forecasts

    8. Saxenda Market Segmentation

    8.1. Global Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Obesity Management (Body Mass Index (BMI) of =30 kg/m²)

    Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities)

    8.2. Global Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Injection

    Pre-filled pens

    8.3. Global Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    8.4. Global Saxenda Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals And Clinics

    Homecare Settings

    9. Global Saxenda Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Saxenda Market Regional And Country Analysis

    10.1. Global Saxenda Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Saxenda Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Saxenda Market

    11.1. Asia-Pacific Saxenda Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Saxenda Market

    12.1. China Saxenda Market Overview

    12.2. China Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Saxenda Market

    13.1. India Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Saxenda Market

    14.1. Japan Saxenda Market Overview

    14.2. Japan Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Saxenda Market

    15.1. Australia Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Saxenda Market

    16.1. South Korea Saxenda Market Overview

    16.2. South Korea Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Saxenda Market

    17.1. Western Europe Saxenda Market Overview

    17.2. Western Europe Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Saxenda Market

    18.1. UK Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Saxenda Market

    19.1. Germany Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Saxenda Market

    20.1. France Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Saxenda Market

    21.1. Eastern Europe Saxenda Market Overview

    21.2. Eastern Europe Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Saxenda Market

    22.1. North America Saxenda Market Overview

    22.2. North America Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Saxenda Market

    23.1. USA Saxenda Market Overview

    23.2. USA Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Saxenda Market

    24.1. Canada Saxenda Market Overview

    24.2. Canada Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Saxenda Market

    25.1. South America Saxenda Market Overview

    25.2. South America Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Saxenda Market

    26.1. Middle East Saxenda Market Overview

    26.2. Middle East Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Saxenda Market

    27.1. Africa Saxenda Market Overview

    27.2. Africa Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Saxenda Market Competitive Landscape And Company Profiles

    28.1. Saxenda Market Competitive Landscape

    28.2. Saxenda Market Company Profiles

    28.2.1. Novo Nordisk Overview, Products and Services, Strategy and Financial Analysis

    28.2.2. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.3. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.4. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.5. 0 Overview, Products and Services, Strategy and Financial Analysis

    29. Global Saxenda Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Saxenda Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Saxenda Market

    32. Recent Developments In The Saxenda Market

    33. Saxenda Market High Potential Countries, Segments and Strategies

    33.1 Saxenda Market In 2029 - Countries Offering Most New Opportunities

    33.2 Saxenda Market In 2029 - Segments Offering Most New Opportunities

    33.3 Saxenda Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Saxenda Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Saxenda Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Saxenda Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: Novo Nordisk Financial Performance
  • Table 61: 0 Financial Performance
  • Table 62: 0 Financial Performance
  • Table 63: 0 Financial Performance
  • Table 64: 0 Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Saxenda Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Saxenda Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Saxenda Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Saxenda Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Saxenda Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Saxenda Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: Novo Nordisk Financial Performance
  • Figure 61: 0 Financial Performance
  • Figure 62: 0 Financial Performance
  • Figure 63: 0 Financial Performance
  • Figure 64: 0 Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Weight Management Global Market Report 2025 – By Diet (Functional Beverages, Functional Food, Dietary Supplements), By Equipment (Fitness, Surgical), By Services (Health Clubs, Consultation Services, Online Weight Loss Services) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Weight Loss Supplements Global Market Report 2025 – By Type (Liquid, Powder, Softgels, Pills, Other Types), By Ingredients (Vitamins & Minerals, Amino Acids, Natural Extracts/Botanicals), By Distribution (Offline Channel, Online Channel), By End User (Under 18 years, 18 to 40 years, 40 to 50 years, Above 50 years) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Weight Loss and Diet Management Global Market Report 2025 – By Diet( Better-For-You-Food and Beverages, Weight Loss Supplements, Meal Replacements, Low-Calorie Sweeteners, Other Diets), By Equipment( Fitness Equipment, Surgical Equipment), By Service( Fitness Center And Health Clubs, Slimming Centers And Commercial Weight Loss Center, Consulting Services, Online Weight Loss Programs), By Application( Small Retail, Online Distribution, Multilevel Marketing, Large Retail, Health and Beauty Stores) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Weight Loss Products And Services Global Market Report 2025 – By Products( Food, Beverage, Supplements, Other Weight Loss Products ), By Services( Fitness Centers, Slimming Centers, Consultation Services, Other Services, Fat Replacers ), By Sales Channel( Supermarkets And Hypermarkets, Convenience Stores, Retail Pharmacies, E-Commerce ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Weight Loss Services Global Market Report 2025 – By Service( Slimming Centers, Fitness centers, Consulting services, Weight loss programs), By Equipment( Fitness equipment, Surgical equipment), By Diet( Meal, Beverages), By Medications( Drugs, Supplements) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Weight Loss Drugs Global Market Report 2025 – By Type (Liquid, Tablets, Capsules), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Weight-Reducing Aid, Fat Absorption Inhibitors, Metabolic Boosters) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Dietary Fibers Global Market Report 2025 – By Product( Soluble dietary fibers, Insoluble dietary fibers), By Raw Material( Fruits and Vegetables, Cereals and Grains, Legumes, Nuts and Seeds), By Application( Food and Beverage, Pharmaceuticals, Animal Feed, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Functional Food Market 2022 - By Product Type (Bakery & Cereals, Dairy Products, Meat, Fish & Eggs, Soy Products, Fats & Oils), By Application (Sports Nutrition, Weight Management, Immunity, Digestive Health, Clinical Nutrition, Cardio Health), By Ingredients (Carotenoids, Dietary Fibers, Fatty Acids, Minerals, Prebiotics & Probiotics, Vitamins, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Saxenda market?

Saxenda is a prescription medication containing liraglutide, designed to aid in weight management for adults with obesity or overweight conditions. It works by mimicking a hormone in the body that regulates appetite, helping individuals reduce caloric intake and achieve sustained weight loss when combined with a reduced-calorie diet and increased physical activity. For further insights on the Saxenda market, request a sample here

How will the Saxenda market drivers and restraints affect the market dynamics? What forces will shape the Saxenda industry going forward?

The Saxenda market major growth driver - Rising Obesity Prevalence Drives Demand For Weight-Loss Treatments. For further insights on the Saxenda market, request a sample here

What is the forecast market size or the forecast market value of the Saxenda market?

The Saxenda market size has grown strongly in recent years. The saxenda market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased prevalence of obesity, growth in sedentary lifestyles, rise in awareness of obesity-related health risks, increased adoption of weight management treatments, and expansion of healthcare access. The saxenda market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing personalized medicine, expanding healthcare infrastructure, rising demand for non-surgical weight loss solutions, and increasing use of digital health tools. Major trends in the forecast period include the emergence of combination therapies for weight loss, increasing availability of prescription weight loss medications, rising adoption of digital health and fitness apps, integration of weight management solutions into primary care, and greater focus on sustainable lifestyle changes. For further insights on the Saxenda market, request a sample here

How is the Saxenda market segmented?

The saxenda market covered in this report is segmented –
1) By Indication: Obesity Management (Body Mass Index (BMI) of =30 kg/m²); Overweight Management (BMI of =27 kg/m² to <30 kg/m² with weight-related comorbidities)
2) By Dosage Form: Injection; Pre-filled pens
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End User: Hospitals And Clinics; Homecare Settings For further insights on the Saxenda market, request a sample here

Which region has the largest share of the Saxenda market? What are the other regions covered in the report?

North America was the largest region in the saxenda market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the saxenda market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Saxenda market, request a sample here.

Who are the major players in the Saxenda market?

Major companies operating in the saxenda market are Novo Nordisk . For further insights on the Saxenda market, request a sample here.

What are the key trends in the Saxenda market?

Major trends in the Saxenda market include Innovative Generic Products Expand Affordable Alternatives For Weight Management. For further insights on the Saxenda market, request a sample here.

What are the major opportunities in the Saxenda market? What are the strategies for the Saxenda market?

For detailed insights on the major opportunities and strategies in the Saxenda market, request a sample here.

How does the Saxenda market relate to the overall economy and other similar markets?

For detailed insights on Saxenda's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Saxenda industry?

For detailed insights on the mergers and acquisitions in the Saxenda industry, request a sample here.

What are the key dynamics influencing the Saxenda market growth? SWOT analysis of the Saxenda market.

For detailed insights on the key dynamics influencing the Saxenda market growth and SWOT analysis of the Saxenda industry, request a sample here.